首页 › 基金 › Artia Global Partners LP › RXRX
Artia Global Partners LP 对 RXRX 的持仓历史
RECURSION PHARMACEUTICALS IN · 医疗保健
Artia Global Partners LP 在 Q3 2026 的 13F 申报中披露持有 RXRX(RECURSION PHARMACEUTICALS IN)334,402 股,市值约 US$1.4M,约占其申报组合的 0.28%,在其申报持仓中市值排名第 43 位。 Artia Global Partners LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Artia Global Partners LP 对 RXRX 的持仓演变
Artia Global Partners LP 于 Q3 2026 首次披露 RXRX 持仓:334,402 股(约 US$1.4M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 334.40K | $1.38M | 新进 |
关于 RXRX 与 13F 数据
RXRX(RECURSION PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 RXRX,申报仓位最大的包括:方舟投资 (US$184.8M), SOFTBANK GROUP CORP. (US$56.3M), MIC Capital Management UK LLP (US$34.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RXRX 的基金
- 方舟投资 44.75M 股 · $184.80M · Q3 2026
- SOFTBANK GROUP CORP. 13.64M 股 · $56.32M · Q3 2026
- MIC Capital Management UK LLP 8.26M 股 · $34.09M · Q3 2026
- Data Collective IV GP, LLC 5.94M 股 · $21.80M · Q2 2026
- GMT CAPITAL CORP 4.86M 股 · $20.06M · Q3 2026
- DCVC Opportunity Fund II GP, LLC 3.95M 股 · $14.50M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 2.68M 股 · $11.06M · Q3 2026
更多关于 Artia Global Partners LP
常见问题
How long has Artia Global Partners LP held RXRX?
Artia Global Partners LP has disclosed RXRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Artia Global Partners LP's current position in RXRX?
As of Q3 2026, Artia Global Partners LP holds 334.40K shares of RXRX (RECURSION PHARMACEUTICALS IN), valued at $1.38M, representing 0.28% of its reported portfolio and ranking #43.
Has Artia Global Partners LP been buying or selling RXRX?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in RXRX.
Which other funds hold RXRX?
Other major institutional holders of RXRX include 方舟投资, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.